2020 Fiscal Year Final Research Report
Identification of a small compound targeting cancer stem cells in cholangiocarcinoma
| Project/Area Number |
17K10716
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | Miyagi Prefectural Hospital Organization Miyagi Cancer Center |
|---|
Principal Investigator |
Yamamoto Kuniharu 地方独立行政法人宮城県立病院機構宮城県立がんセンター(研究所), がん幹細胞研究部, 特任研究員 (00375073)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
玉井 恵一 地方独立行政法人宮城県立病院機構宮城県立がんセンター(研究所), がん幹細胞研究部, 部長 (40509262)
|
|---|
| Project Period (FY) |
2017-04-01 – 2021-03-31
|
| Keywords | 胆管癌 |
|---|
| Outline of Final Research Achievements |
Recently, Cancer stem cell is recognized as therapy-resistant cells because its population is dominant in quiescent phase. We searched a new cancer stem cell-related gene, and found BEX2. BEX2 is indispensable in maintaining dormant cancer stem cells and could be a promising therapeutic target.
|
| Free Research Field |
腫瘍学
|
| Academic Significance and Societal Importance of the Research Achievements |
私たちは難治性癌である胆管癌の新たな治療標的を同定した。今後、詳細な分子機構を明らかにすることで、新規治療に結びつく可能性がある。
|
